全球医疗事务外包市场 - 市场规模、份额、成长分析：按服务（医疗监测、医学写作和出版）、按行业（医疗设备、製药和生物製药） - 行业预测（2023-2030）

2021年全球医疗事务外包市场规模为14.9亿美元，预测在预测期内（2023-2030年）年复合成长率为13.6%，从2022年的17亿美元增长到2030年。2019年增至47.1亿美元。

由于感染疾病和非感染疾病的流行导致临床试验大幅增加，全球医疗事务外包市场正在显着扩大。临床活动的激增急剧增加了对医疗设备和创新药物的需求，从而增加了对医疗外包解决方案的需求。

此外，委外研发机构提供的极具吸引力的成本效益和一流服务的结合推动了这个市场的成长。严格法规的存在也强调了对专业能力的需求，进一步巩固了市场预测。

这些要素共同创造了有利于医事外包领域发展的环境。全球疫情大流行的影响波及各行业，包括医疗事务外包。

儘管法规和外包部门面临障碍，但 COVID-19 的爆发要求製药业专业人员改变医疗事务的惯例。这种调整导致了虚拟科学参与的激增和对科学交流的重视。从长远来看，这些变化预计将再形成医疗事务团队的结构和职能。

预计新领域将成为医疗事务领域不可或缺的一部分，例如透过特定医疗管道促进先进治疗的获得、与病患小组在专科护理中发挥关键作用。

医药和医疗设备领域面临价格限制、严格法规、专利到期挑战，导致报酬率下降。医疗事务业务正在成为生物製药和製药公司的策略和竞争工具，这主要是由于其节省成本的效果。

製药和医疗设备企业透过将医疗事务业务委託给委外研发机构（CRO），可以减少业务费用、减少法律责任、加强法规合规性、避免程序瓶颈，可以透过与优秀外包合作伙伴的合作来实现。随着公司努力最佳化其能力并应对充满挑战的企业环境，这种趋势预计将持续下去。

在医疗保健领域，越来越需要具体证据来证明产品的有效性和安全性。医疗事务外包提供者在创建、评估和分发真实资料方面发挥着至关重要的作用。这些资料对于提高药品和医疗设备的可靠性发挥作用。

该报告研究了全球医疗事务外包市场，并提供了市场概述、按服务、行业、地区分類的趋势以及参与市场的公司概况。

目录

执行摘要

母市场分析

市场规模

• 市场动态
• 促进因素
• 机会
• 抑制因素
• 任务

关键市场洞察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 趋势分析
• 启动分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 总体经济指标
• 顶级投资分析
• 关键成功要素
• 竞争程度

市场动态及预测

• 市场动态
• 促进因素
• 机会
• 抑制因素
• 任务
• 法规状况
• 波特分析

全球医疗事务外包市场（按服务）

• 市场概况
• 医疗监测
• 医学写作/出版
• 医疗资讯
• 医学科学联络员
• 其他的

全球医疗事务外包市场（按行业）

• 市场概况
• 医疗设备、药品和生物製药

全球医疗事务外包市场（按地区）

• 市场概况
• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东/非洲

竞争形势

• 主要企业简介
  • IQVIA Inc.
  • Syneos Health Inc.
  • PAREXEL International Corporation
  • ICON plc
  • PPD公司
  • Pharmaceutical Product Development, LLC（PPD）
  • Covance Inc
  • PRA Health Sciences, Inc.
  • Medpace Holdings, Inc.
  • Charles River Laboratories International, Inc.
  • ProPharma Group
  • The Medical Affairs Company, LLC
  • Indegene, Inc
  • Ashfield Healthcare Communications Group
  • Accenture plc
  • MMS Holdings Inc.
  • Clinipace Worldwide
  • Max Neeman International
  • Freyr Solutions
  • Comprehend Systems, Inc.

Global Medical Affairs Outsourcing Market size was valued at USD 1.49 billion in 2021 and is poised to grow from USD 1.7 billion in 2022 to USD 4.71 billion by 2030, at a CAGR of 13.6% during the forecast period (2023-2030).

The global market for outsourcing medical affairs is undergoing significant expansion, driven by a notable increase in clinical trials due to the growing prevalence of communicable and non-communicable diseases. This surge in clinical activity has spiked demand for medical devices and innovative drugs, thereby intensifying the necessity for medical outsourcing solutions.

Furthermore, this market growth is propelled by the appealing amalgamation of cost-efficiency and top-notch services offered by contract research organizations. The presence of strict regulatory demands also underscores the requirement for specialized proficiency, further fortifying the market's prospects.

These factors collectively foster an environment conducive to the progression of the medical affairs outsourcing sector. The widespread effects of the global pandemic have reverberated across various industries, including medical affairs outsourcing.

Despite the hurdles confronted by regulatory and outsourcing units, the outbreak of COVID-19 has necessitated a shift in the routines of pharmaceutical industry professionals in medical affairs. This adjustment has given rise to a considerable surge in virtual scientific engagements and an elevated emphasis on scientific communication. In the long run, these transformations are predicted to reshape the configuration and duties of medical affairs teams.

Emergent domains, such as facilitating access to advanced treatments through specific healthcare channels, active engagement with patient groups, and pivotal roles in specialty care, are envisioned to become integral facets of the medical affairs realm.

Pharmaceutical and medical device sectors confront challenges like pricing constraints, rigorous regulations, and patent expirations, leading to narrowed profit margins. Contract medical affairs services are emerging as a strategic and competitive instrument among biopharmaceutical and pharmaceutical enterprises, primarily due to the cost-saving benefits they provide.

By delegating medical affairs services to contract research organizations (CROs), pharmaceutical and medical device companies can curtail operational expenses, mitigate liability exposure, enhance compliance with regulations, and avert procedural bottlenecks through partnerships with adept outsourcing collaborators. This inclination is likely to persist as businesses strive to optimize their functions and navigate the demanding corporate landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Affairs Outsourcing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Driver

The healthcare sector's demand for tangible evidence to substantiate the effectiveness and safety of products is on the rise. In this context, providers of medical affairs outsourcing assume a pivotal role in producing, evaluating, and distributing real-world data. This data serves to bolster the credibility of pharmaceutical products and medical devices.

Restraint

Delegating medical affairs responsibilities externally can present obstacles in upholding uniform quality and ensuring alignment with internal benchmarks and regulatory mandates. To effectively address these challenges, organizations need to establish robust frameworks for oversight and evaluation.

Market Trends

The demand for real-world evidence is on a steady rise among pharmaceutical and medical device firms, as they seek to establish the effectiveness, safety, and value of their products. In this context, medical affairs outsourcing entities are assuming a pivotal role in the generation and analysis of real-world data. This support aids companies in making informed decisions grounded in evidence and facilitates the compilation of regulatory submissions.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune
• Research Methodology
• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Market Dynamics & Outlook
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Medical Affairs Outsourcing Market by Services
• Market Overview
• Medical Monitoring
• Medical Writing & Publishing
• Medical Information
• Medical Science Liaisons
• Others
• Global Medical Affairs Outsourcing Market by Industry
• Market Overview
• Medical Devices and Pharma & biopharmaceuticals
• Global Medical Affairs Outsourcing Market Size by Region
• Market Overview
• North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
• IQVIA Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Syneos Health Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • PAREXEL International Corporation (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ICON plc (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • PPD, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pharmaceutical Product Development, LLC (PPD) (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Covance Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • PRA Health Sciences, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medpace Holdings, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Charles River Laboratories International, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ProPharma Group (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • The Medical Affairs Company, LLC (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Indegene, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ashfield Healthcare Communications Group (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Accenture plc (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • MMS Holdings Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Clinipace Worldwide (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Max Neeman International (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Freyr Solutions (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Comprehend Systems, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments